Results from the NRG Oncology GOG-0263 phase III clinical trial testing the addition of cisplatin-based chemotherapy to adjuvant radiotherapy following radical hysterectomy and lymphadenectomy for patients with early-stage, intermediate-risk cervical carcinoma indicated that the addition of chemotherapy did not improve outcomes for patients and led to increased toxicity for patients.
Man receives the first eye transplant plus a new face. It’s a step toward one day restoring sight
NEW YORK — Surgeons have performed the world’s first transplant of an entire human eye, an extraordinary addition to a face transplant — although it’s
November 9, 2023